Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice

American Journal of Physiology. Endocrinology and Metabolism
Jonathan D SchertzerGordon S Lynch

Abstract

The absence of dystrophin and resultant disruption of the dystrophin glycoprotein complex renders skeletal muscles of dystrophic patients and dystrophic mdx mice susceptible to contraction-induced injury. Strategies to reduce contraction-induced injury are of critical importance, because this mode of damage contributes to the etiology of myofiber breakdown in the dystrophic pathology. Transgenic overexpression of insulin-like growth factor-I (IGF-I) causes myofiber hypertrophy, increases force production, and can improve the dystrophic pathology in mdx mice. In contrast, the predominant effect of continuous exogenous administration of IGF-I to mdx mice at a low dose (1.0-1.5 mg.kg(-1).day(-1)) is a shift in muscle phenotype from fast glycolytic toward a more oxidative, fatigue-resistant, slow muscle without alterations in myofiber cross-sectional area, muscle mass, or maximum force-producing capacity. We found that exogenous administration of IGF-I to mdx mice increased myofiber succinate dehydrogenase activity, shifted the overall myosin heavy chain isoform composition toward a slower phenotype, and, most importantly, reduced contraction-induced damage in tibialis anterior muscles. The deficit in force-producing capacity after...Continue Reading

References

Aug 1, 1993·Journal of Muscle Research and Cell Motility·P MoensG Maréchal
Sep 1, 1994·Journal of Applied Physiology·G L WarrenR B Armstrong
Aug 1, 1993·The Journal of Physiology·G L WarrenR B Armstrong
Nov 1, 1993·Journal of Applied Physiology·R J Talmadge, R R Roy
May 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·N Hämäläinen, D Pette
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·B J PetrofH L Sweeney
Nov 1, 1996·The American Journal of Physiology·P C MacphersonJ A Faulkner
Apr 16, 1998·Journal of Muscle Research and Cell Motility·S V Brooks
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·E R Barton-DavisH L Sweeney
Sep 26, 2000·American Journal of Physiology. Cell Physiology·G S LynchJ A Faulkner
Apr 3, 2002·The Journal of Cell Biology·Elisabeth R BartonH Lee Sweeney
Apr 20, 2002·Journal of Muscle Research and Cell Motility·C DellorussoS V Brooks
Sep 11, 2002·Neuromuscular Disorders : NMD·Jeannine M ScottJeffrey S Chamberlain
Nov 18, 2003·The Journal of Physiology·James G RyallGordon S Lynch
Jan 13, 2004·Journal of Applied Physiology·Christina M Consolino, Susan V Brooks
Aug 10, 2004·Clinical and Experimental Pharmacology & Physiology·Gordon S Lynch
Oct 14, 2004·American Journal of Physiology. Endocrinology and Metabolism·Jonathan D SchertzerGordon S Lynch
Oct 29, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Thea ShavlakadzeMiranda D Grounds
Jan 15, 2005·The Journal of Clinical Investigation·Yao-Hua SongPatrick Delafontaine
Feb 8, 2005·Neuromuscular Disorders : NMD·Thea ShavlakadzeMiranda D Grounds
Mar 29, 2005·The American Journal of Pathology·Leah J HarcourtGordon S Lynch
Jul 9, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Daniela Danieli-BettoRomeo Betto
Aug 16, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Simone AbmayrJeffrey S Chamberlain
Nov 29, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jonathan D SchertzerGordon S Lynch

❮ Previous
Next ❯

Citations

Apr 5, 2011·The Journal of Biological Chemistry·Friedrich MetzgerHans-Joachim Schoenfeld
Aug 19, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·James G RyallGordon S Lynch
Jun 3, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Herman VandenburghBrian S Tseng
May 24, 2008·Clinical and Experimental Pharmacology & Physiology·Gordon S LynchJames G Ryall
Oct 3, 2013·Human Molecular Genetics·Colleen E D'ArcyMeagan J McGrath
Apr 24, 2013·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Karen J B MartinsGordon S Lynch
Aug 7, 2009·The Journal of Nutrition, Health & Aging·G OnderF Landi
Feb 18, 2011·Expert Opinion on Emerging Drugs·Stefan M Gehrig, Gordon S Lynch
Aug 30, 2012·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Christy L WilloughbyLinda K McLoon
Sep 13, 2012·Neuromuscular Disorders : NMD·Meilan M RutterBrenda L Wong
Mar 20, 2012·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Stefan M GehrigFriedrich Metzger
Sep 3, 2008·Mechanisms of Ageing and Development·Silvia GiovanniniChristiaan Leeuwenburgh
Mar 28, 2008·Trends in Biotechnology·Maria MinunniMarco Mascini
Jan 30, 2007·Pharmacology & Therapeutics·Gordon S LynchJames G Ryall
Mar 5, 2009·Muscle & Nerve·Christopher F SpurneyKanneboyina Nagaraju
Oct 13, 2011·The Journal of Pathology·Virginie Carmignac, Madeleine Durbeej
May 1, 2015·Annals of Neurology·Adrian G ToddDarin J Falk
Jun 1, 2013·Clinical Science·Callum Livingstone
Sep 14, 2014·Human Molecular Genetics·Darin J FalkBarry J Byrne
Oct 30, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kristy SwiderskiGordon Stuart Lynch
Jan 23, 2017·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·H KletzlF Metzger
Mar 1, 2018·Frontiers in Endocrinology·Farhad DehkhodaAndrew J Brooks
Jan 20, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Shi Yu YangMarc C Winslet
Nov 17, 2009·Journal of Applied Physiology·Bert BlaauwCarlo Reggiani
Nov 9, 2007·American Journal of Physiology. Cell Physiology·Jonathan D SchertzerGordon S Lynch
Jan 1, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Justin L ChenPaul Gregorevic
Jul 14, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kate T MurphyGordon S Lynch
May 26, 2017·American Journal of Physiology. Endocrinology and Metabolism·Marin Jane McBrideJonathan D Schertzer
Mar 19, 2020·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Alex Bernard AddinsallNicole Stupka
Feb 3, 2021·Physiological Reports·Sally E McBeanChris van der Poel
Feb 26, 2009·Genes & Development·Kyle R LegateReinhard Fässler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.